Connecticut 2022 Regular Session

Connecticut House Bill HB05155

Introduced
2/17/22  
Introduced
2/17/22  
Refer
2/17/22  
Refer
2/17/22  
Report Pass
3/15/22  
Report Pass
3/15/22  
Refer
3/24/22  
Refer
3/24/22  

Caption

An Act Concerning The Safe Storage And Disposal Of Opioid Drugs, Cannabis And Cannabis Products.

Impact

If enacted, HB 05155 is poised to impact state laws significantly by introducing new requirements for consumer safety relating to the management of opioids and cannabis. The Department will be tasked with establishing clear guidelines regarding not only the proper storage but also the disposal of these products to minimize their risk to minors and the environment. The bill also includes requirements for labels and signs that communicate these safety measures, thereby facilitating greater awareness among consumers.

Summary

House Bill 05155, titled 'An Act Concerning The Safe Storage And Disposal Of Opioid Drugs, Cannabis And Cannabis Products', aims to enhance the safety protocols regarding the storage and disposal of both opioid drugs and cannabis products. This legislation mandates the Department of Consumer Protection to develop materials that inform consumers about best practices for safely storing these substances, particularly to prevent accidental ingestion by children. The bill represents an ongoing effort to address the public health crises associated with opioid misuse and the recently legalized use of cannabis in the state.

Sentiment

The sentiment surrounding HB 05155 appears to be supportive across several sectors, reflecting a common concern for public health and safety. The absence of notable opposition points to a consensus on the importance of safeguarding children from potential dangers associated with drug access. Stakeholders in both the cannabis and pharmaceutical industries recognize the necessity of promoting safe practices among consumers.

Contention

While the overall sentiment is positive, notable points of contention may emerge regarding the implementation of the bill's requirements and potential regulatory burdens on businesses. As the state defines the specific regulatory measures—such as labeling requirements and consumer education strategies—industry representatives may raise concerns about compliance costs and the operational impact on cannabis dispensaries and pharmacies. The anticipated focus on public safety, however, stands as a strong justification for these regulations.

Companion Bills

No companion bills found.

Previously Filed As

CT HB05150

An Act Concerning Cannabis And Hemp Regulation.

CT HB05235

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Cannabis Regulation.

CT SB00200

An Act Concerning Social Equity Applicants, Infused Beverages And Moderate-thc Hemp Products.

CT SB00449

An Act Concerning A Study Of State Taxation.

CT HB05249

An Act Concerning Personal Opioid Drug Deactivation And Disposal Systems And The Opioid Settlement Fund.

CT HB05149

An Act Concerning Cafe And Package Store Permittees.

CT SB00292

An Act Concerning The Use Of Pfas In Certain Products.

CT SB00274

An Act Concerning Opioids.

CT SB00444

An Act Concerning The Modification Of Sentences For Cannabis-related Offenses.

CT SB00133

An Act Concerning Regulation Of Prescription Drugs And Related Professions.

Similar Bills

No similar bills found.